Metatissue
Metatissue is a privately held Portuguese biotechnology company, founded in 2018 and headquartered in Ílhavo, that designs and produces human-based products for cell culture and tissue engineering. The 1-10 employee firm serves life sciences and biomedical research customers.
- Company typePrivate
- Founded2018
- HeadquartersÍlhavo, Portugal
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Metatissue does
Metatissue is a privately held Portuguese biotechnology company founded in 2018 and headquartered in Ílhavo, Portugal. According to its firmographic record, the company focuses on the design and production of human-based products for cell culture and tissue engineering, serving the life sciences research and biomedical markets. The company's intended customer base implicitly spans academic research laboratories, pharmaceutical R&D, and regenerative medicine/biomaterials workflows, though no specific customer segments, logos, or contracted relationships have been disclosed.
The company operates at micro-scale, reporting 1-10 employees, and remains privately held with no public-market listing. Its commercial mechanics are not characterized in the source material: no pricing model, distribution channels, marketing channels, customer mix, or product catalog was disclosed. The company's primary web property (metatissue.com) was inaccessible during data collection, returning only a loader/verification page rather than substantive content. No leadership team, contacts, social profiles, or operating geographies were documented. The sole resolvable source identifier confirms only that the entity is in operating status.
No specific products, services, patents, certifications, funding history, partnerships, or awards appear in the available data. As a result, the technology stack, manufacturing process, proprietary know-how, and revenue model cannot be characterized with specificity. The cell culture and tissue engineering positioning suggests adjacency to the broader human-cell-derived reagents, 3D cell culture scaffolds, and tissue model markets, but this remains an inference based on the company description rather than evidence-backed fact.
Metatissue firmographics
Firmographics- Name
- Metatissue
- Website
- https://metatissue.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Metatissue is a privately held Portuguese biotechnology company, founded in 2018 and headquartered in Ílhavo, that designs and produces human-based products for cell culture and tissue engineering. The 1-10 employee firm serves life sciences and biomedical research customers.
- Ownership category
- akta.pro rank
Where Metatissue is headquartered
LocationHeadquarters
- HQ city
- Ílhavo
- HQ country
- Portugal
- HQ region
- Europe
Markets served
Metatissue business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Metatissue product offering
Product offeringCore offering
Metatissue is a biotechnology company focusing on the design and production of human-based products for cell culture and tissue engineering. The company manufactures biological inputs intended for use in laboratory cell culture workflows and tissue engineering applications.
Product overview
No product information available.
Differentiator
Problem solved
Functional benefit
Products and services
- Human-based products for cell culture and tissue engineering
Companies that use Metatissue
Customer profileIdeal customer profiles1 record
Metatissue technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Metatissue competitors and assessment
Company assessmentDirect peers
- Organogenesis Holdings: Organogenesis is a commercial-stage regenerative medicine company developing human-derived wound care and surgical tissue products. Comparable to Metatissue in using human-based biological substrates for tissue repair and engineering applications.
- CellGenix: CellGenix develops and manufactures GMP-grade raw materials and cell culture media for cell and gene therapy manufacturing. Overlaps with Metatissue in supplying human-relevant cell culture consumables to tissue engineering and advanced therapy developers.
- PromoCell: PromoCell GmbH manufactures primary human cells, media, and cell culture reagents for research and cell therapy applications. Directly comparable to Metatissue as a supplier of human-based cell culture products used in tissue engineering and regenerative medicine workflows.
- TissueTech: TissueTech develops and commercializes human birth tissue-derived products for wound healing and ocular surface regenerative applications. Directly comparable to Metatissue in leveraging human-derived biological materials for tissue engineering and regenerative medicine.
- Stemcell Technologies: STEMCELL Technologies is a major developer of specialty cell culture media, separation products, and instruments for stem cell research and regenerative medicine. Comparable to Metatissue as a provider of cell culture inputs used in tissue engineering pipelines.
Broad incumbents
- Lonza Group: Lonza is a global contract development and manufacturing organization with a large cell and gene therapy services and products portfolio. Comparable to Metatissue at the category level as a supplier of cell culture media and bioprocess inputs used in tissue engineering, though operating at vastly larger scale and breadth.
- Thermo Fisher Scientific (Gibco): Gibco/Thermo Fisher is the dominant supplier of cell culture media, sera, and reagents used across regenerative medicine and tissue engineering. Comparable to Metatissue at the category level, though operating as a global incumbent rather than a focused human-derived specialty player.
- Corning Life Sciences: Corning supplies cell culture vessels, extracellular matrices (e.g., Matrigel-equivalent offerings), and media used in tissue engineering workflows. Comparable to Metatissue as a broad incumbent in cell culture consumables, though with a much wider product portfolio.
- Merck KGaA (Sigma-Aldrich / BioReliance): Merck's life science division supplies cell culture media, raw materials, and bioprocess services for cell and gene therapy manufacturing. Comparable to Metatissue as a supplier of inputs for tissue engineering and cell therapy workflows at much greater scale.
Emerging players
- MatTek Life Sciences: MatTek develops human tissue models and cell culture systems used in research and toxicology testing. Comparable to Metatissue as a developer of human-based tissue and cell culture products, with overlapping end users in academic and translational research.
Market position
Strengths3 records
Weaknesses4 records
Key risks5 records
Key highlights4 records
Customer concentration
Metatissue social profiles
Digital presenceMetatissue financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metatissue leadership team
Management profileNumber of profiles
Metatissue funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metatissue M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metatissue
What does Metatissue do?
Metatissue is a biotechnology company focusing on the design and production of human-based products for cell culture and tissue engineering. The company manufactures biological inputs intended for use in laboratory cell culture workflows and tissue engineering applications.
Is Metatissue a public or private company?
Metatissue is a private company. It is classified as unknown and is currently operating.
When was Metatissue founded?
Metatissue was founded in 2018. It employs 1 to 10 people.
Where is Metatissue based?
Metatissue is headquartered in Ílhavo, Portugal, in the Europe region.
Who are Metatissue's main competitors?
Direct peers on record are Organogenesis Holdings, CellGenix, PromoCell, TissueTech and Stemcell Technologies. Broad incumbents are Lonza Group, Thermo Fisher Scientific (Gibco), Corning Life Sciences and Merck KGaA (Sigma-Aldrich / BioReliance). MatTek Life Sciences is listed as an emerging player.
Does Metatissue have an API?
No public API is recorded for Metatissue.